{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:02:48Z","timestamp":1793754168496,"version":"4.6.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T00:00:00Z","timestamp":1516320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s13346-018-0479-7","type":"journal-article","created":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T18:22:03Z","timestamp":1516386123000},"page":"1726-1739","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Continuous manufacturing of co-crystals: challenges and prospects"],"prefix":"10.1007","volume":"8","author":[{"given":"Rahul B.","family":"Chavan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Thipparaboina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balvant","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalini R.","family":"Shastri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,19]]},"reference":[{"issue":"11","key":"479_CR1","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1111\/j.2042-7158.2010.01030.x","volume":"62","author":"T Loftsson","year":"2010","unstructured":"Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins: basic science and product development. J Pharm Pharmacol. 2010;62(11):1607\u201321. \n                    https:\/\/doi.org\/10.1111\/j.2042-7158.2010.01030.x\n                    \n                  .","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"479_CR2","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1021\/cg3002948","volume":"12","author":"S Aitipamula","year":"2012","unstructured":"Aitipamula S, Banerjee R, Bansal AK, Biradha K, Cheney ML, Choudhury AR, et al. Polymorphs, salts, and cocrystals: what\u2019s in a name? Cryst Growth Des. 2012;12(5):2147\u201352. \n                    https:\/\/doi.org\/10.1021\/cg3002948\n                    \n                  .","journal-title":"Cryst Growth Des"},{"issue":"3","key":"479_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.drudis.2016.02.001","volume":"21","author":"R Thipparaboina","year":"2016","unstructured":"Thipparaboina R, Kumar D, Chavan RB, Shastri NR. Multidrug co-crystals: towards the development of effective therapeutic hybrids. Drug Discov Today. 2016;21(3):481\u201390. \n                    https:\/\/doi.org\/10.1016\/j.drudis.2016.02.001\n                    \n                  .","journal-title":"Drug Discov Today"},{"issue":"3","key":"479_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12039-010-0035-6","volume":"122","author":"A Nangia","year":"2010","unstructured":"Nangia A. Supramolecular chemistry and crystal engineering. J Chem Sci. 2010;122(3):295\u2013310. \n                    https:\/\/doi.org\/10.1007\/s12039-010-0035-6\n                    \n                  .","journal-title":"J Chem Sci"},{"issue":"12","key":"479_CR5","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1021\/acs.cgd.5b01187","volume":"15","author":"R Thipparaboina","year":"2015","unstructured":"Thipparaboina R, Kumar D, Mittapalli S, Balasubramanian S, Nangia A, Shastri NR. Ionic, neutral, and hybrid acid\u2013base crystalline adducts of lamotrigine with improved pharmaceutical performance. Cryst Growth Des. 2015;15(12):5816\u201326. \n                    https:\/\/doi.org\/10.1021\/acs.cgd.5b01187\n                    \n                  .","journal-title":"Cryst Growth Des"},{"issue":"8","key":"479_CR6","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1039\/c000614a","volume":"12","author":"S Chattoraj","year":"2010","unstructured":"Chattoraj S, Shi L, Sun CC. Understanding the relationship between crystal structure, plasticity and compaction behaviour of theophylline, methyl gallate, and their 1: 1 co-crystal. CrystEngComm. 2010;12(8):2466\u201372. \n                    https:\/\/doi.org\/10.1039\/c000614a\n                    \n                  .","journal-title":"CrystEngComm"},{"key":"479_CR7","unstructured":"US-FDA. Regulatory classification of pharmaceutical co-crystals guidance for industry. 2016."},{"key":"479_CR8","unstructured":"European Medicines Agency. Reflection paper on the use of cocrystals of active substances in medicinal products 2015."},{"issue":"2","key":"479_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.xphs.2016.10.021","volume":"106","author":"DP Kale","year":"2017","unstructured":"Kale DP, Zode SS, Bansal AK. Challenges in translational development of pharmaceutical Cocrystals. J Pharm Sci. 2017;106(2):457\u201370. \n                    https:\/\/doi.org\/10.1016\/j.xphs.2016.10.021\n                    \n                  .","journal-title":"J Pharm Sci"},{"key":"479_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.addr.2017.05.001","volume":"117","author":"D Hasa","year":"2017","unstructured":"Hasa D, Jones W. Screening for new pharmaceutical solid forms using mechanochemistry: a practical guide. Adv Drug Deliv Rev. 2017;117:147\u201361. \n                    https:\/\/doi.org\/10.1016\/j.addr.2017.05.001\n                    \n                  .","journal-title":"Adv Drug Deliv Rev"},{"key":"479_CR11","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1039\/b207369m","volume":"20","author":"N Shan","year":"2002","unstructured":"Shan N, Toda F, Jones W. Mechanochemistry and co-crystal formation: effect of solvent on reaction kinetics. Chem Comm. 2002;20:2372\u20133.","journal-title":"Chem Comm"},{"issue":"6","key":"479_CR12","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1021\/acs.cgd.6b00402","volume":"16","author":"HG Moradiya","year":"2016","unstructured":"Moradiya HG, Islam MT, Scoutaris N, Halsey SA, Chowdhry BZ, Douroumis D. Continuous manufacturing of high quality pharmaceutical cocrystals integrated with process analytical tools for in-line process control. Cryst Growth Des. 2016;16(6):3425\u201334. \n                    https:\/\/doi.org\/10.1021\/acs.cgd.6b00402\n                    \n                  .","journal-title":"Cryst Growth Des"},{"key":"479_CR13","unstructured":"Yu L. Continuous manufacturing has a strong impact on drug quality. FDA Voice. 2016;12"},{"issue":"4","key":"479_CR14","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1021\/acs.cgd.6b01866","volume":"17","author":"V Svoboda","year":"2017","unstructured":"Svoboda V, MacFhionnghaile P, McGinty J, Connor LE, Oswald ID, Sefcik J. Continuous cocrystallization of benzoic acid and isonicotinamide by mixing-induced supersaturation: exploring opportunities between reactive and antisolvent crystallization concepts. Cryst Growth Des. 2017;17(4):1902\u20139. \n                    https:\/\/doi.org\/10.1021\/acs.cgd.6b01866\n                    \n                  .","journal-title":"Cryst Growth Des"},{"key":"479_CR15","unstructured":"Current good manufacturing practice for manufacturing, processing, packing, or holding of drugs, US FDA Center for Drug Evaluation and Research. FDA. 2014."},{"issue":"1","key":"479_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1021\/cg401375a","volume":"14","author":"H Moradiya","year":"2013","unstructured":"Moradiya H, Islam MT, Woollam GR, Slipper IJ, Halsey S, Snowden MJ, et al. Continuous cocrystallization for dissolution rate optimization of a poorly water-soluble drug. Cryst Growth Des. 2013;14(1):189\u201398.","journal-title":"Cryst Growth Des"},{"issue":"9","key":"479_CR17","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1021\/acs.oprd.5b00225","volume":"19","author":"T McGlone","year":"2015","unstructured":"McGlone T, Briggs NE, Clark CA, Brown CJ, Sefcik J, Florence AJ. Oscillatory flow reactors (OFRs) for continuous manufacturing and crystallization. Org Process Res Dev. 2015;19(9):1186\u2013202. \n                    https:\/\/doi.org\/10.1021\/acs.oprd.5b00225\n                    \n                  .","journal-title":"Org Process Res Dev"},{"issue":"12","key":"479_CR18","doi-asserted-by":"publisher","first-page":"5897","DOI":"10.1021\/cg300763t","volume":"12","author":"T Lee","year":"2012","unstructured":"Lee T, Chen HR, Lin HY, Lee HL. Continuous co-crystallization as a separation technology: the study of 1: 2 co-crystals of phenazine\u2013vanillin. Cryst Growth Des. 2012;12(12):5897\u2013907. \n                    https:\/\/doi.org\/10.1021\/cg300763t\n                    \n                  .","journal-title":"Cryst Growth Des"},{"issue":"7","key":"479_CR19","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1205\/0263876041596670","volume":"82","author":"G Westhoff","year":"2004","unstructured":"Westhoff G, Kramer H, Jansens P, Grievink J. Design of a multi-functional crystallizer for research purposes. Chem Eng Res Des. 2004;82(7):865\u201380. \n                    https:\/\/doi.org\/10.1205\/0263876041596670\n                    \n                  .","journal-title":"Chem Eng Res Des"},{"issue":"10","key":"479_CR20","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1021\/acs.cgd.5b00599","volume":"15","author":"KA Powell","year":"2015","unstructured":"Powell KA, Bartolini G, Wittering KE, Saleemi AN, Wilson CC, Rielly CD, et al. Toward continuous crystallization of urea-barbituric acid: a polymorphic co-crystal system. Cryst Growth Des. 2015;15(10):4821\u201336. \n                    https:\/\/doi.org\/10.1021\/acs.cgd.5b00599\n                    \n                  .","journal-title":"Cryst Growth Des"},{"key":"479_CR21","volume-title":"Process and apparatus for intimately contacting fluids","author":"WJD Dijck","year":"1935","unstructured":"Dijck WJD. Process and apparatus for intimately contacting fluids. Google Patents; 1935."},{"issue":"2","key":"479_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/cjce.5450660206","volume":"66","author":"M Baird","year":"1988","unstructured":"Baird M, Rama Rao N. Characteristics of a countercurrent reciprocating plate bubble column. II. Axial mixing and mass transfer. Can J Chem Eng. 1988;66(2):222\u201331.","journal-title":"Can J Chem Eng"},{"key":"479_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.compchemeng.2012.09.015","volume":"49","author":"X Nogueira","year":"2013","unstructured":"Nogueira X, Taylor BJ, Gomez H, Colominas I, Mackley MR. Experimental and computational modeling of oscillatory flow within a baffled tube containing periodic-tri-orifice baffle geometries. Comput Chem Eng. 2013;49:1\u201317. \n                    https:\/\/doi.org\/10.1016\/j.compchemeng.2012.09.015\n                    \n                  .","journal-title":"Comput Chem Eng"},{"issue":"3","key":"479_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/(SICI)1097-4660(199707)69:3<321::AID-JCTB717>3.0.CO;2-Q","volume":"69","author":"P Gough","year":"1997","unstructured":"Gough P, Ni X, Symes KC. Experimental flow visualisation in a modified pulsed baffled reactor. J Chem Technol Biot. 1997;69(3):321\u20138. \n                    https:\/\/doi.org\/10.1002\/(SICI)1097-4660(199707)69:3<321::AID-JCTB717>3.0.CO;2-Q\n                    \n                  .","journal-title":"J Chem Technol Biot"},{"issue":"26","key":"479_CR25","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.1039\/C4CE00154K","volume":"16","author":"L Zhao","year":"2014","unstructured":"Zhao L, Raval V, Briggs NE, Bhardwaj RM, McGlone T, Oswald ID, et al. From discovery to scale-up: \u03b1-lipoic acid: nicotinamide co-crystals in a continuous oscillatory baffled crystalliser. CrystEngComm. 2014;16(26):5769\u201380. \n                    https:\/\/doi.org\/10.1039\/C4CE00154K\n                    \n                  .","journal-title":"CrystEngComm"},{"key":"479_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jcrysgro.2014.02.003","volume":"392","author":"S Kudo","year":"2014","unstructured":"Kudo S, Takiyama H. Production method of carbamazepine\/saccharin cocrystal particles by using two solution mixing based on the ternary phase diagram. J Cryst Growth. 2014;392:87\u201391. \n                    https:\/\/doi.org\/10.1016\/j.jcrysgro.2014.02.003\n                    \n                  .","journal-title":"J Cryst Growth"},{"issue":"1","key":"479_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ijpharm.2013.04.012","volume":"450","author":"I-C Wang","year":"2013","unstructured":"Wang I-C, Lee M-J, Sim S-J, Kim W-S, Chun N-H, Choi GJ. Anti-solvent co-crystallization of carbamazepine and saccharin. Int J Pharm. 2013;450(1):311\u201322. \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2013.04.012\n                    \n                  .","journal-title":"Int J Pharm"},{"key":"479_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jiec.2016.01.027","volume":"36","author":"M Nishimaru","year":"2016","unstructured":"Nishimaru M, Kudo S, Takiyama H. Cocrystal production method reducing deposition risk of undesired single component crystals in anti-solvent cocrystallization. J Ind Eng Chem. 2016;36:40\u20133. \n                    https:\/\/doi.org\/10.1016\/j.jiec.2016.01.027\n                    \n                  .","journal-title":"J Ind Eng Chem"},{"key":"479_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jcrysgro.2017.04.017","volume":"470","author":"M Nishimaru","year":"2017","unstructured":"Nishimaru M, Nakasa M, Kudo S, Takiyama H. Operation condition for continuous anti-solvent crystallization of CBZ-SAC cocrystal considering deposition risk of undesired crystals. J Cryst Growth. 2017;470:89\u201393. \n                    https:\/\/doi.org\/10.1016\/j.jcrysgro.2017.04.017\n                    \n                  .","journal-title":"J Cryst Growth"},{"issue":"9","key":"479_CR30","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1021\/acs.molpharmaceut.6b00134","volume":"13","author":"S Li","year":"2016","unstructured":"Li S, Yu T, Tian Y, McCoy CP, Jones DS, Andrews GP. Mechanochemical synthesis of pharmaceutical cocrystal suspensions via hot melt extrusion: feasibility studies and physicochemical characterization. Mol Pharm. 2016;13(9):3054\u201368. \n                    https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00134\n                    \n                  .","journal-title":"Mol Pharm"},{"issue":"4","key":"479_CR31","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/jps.21942","volume":"99","author":"C Medina","year":"2010","unstructured":"Medina C, Daurio D, Nagapudi K, Alvarez-Nunez F. Manufacture of pharmaceutical co-crystals using twin screw extrusion: a solvent-less and scalable process. J Pharm Sci. 2010;99(4):1693\u20136. \n                    https:\/\/doi.org\/10.1002\/jps.21942\n                    \n                  .","journal-title":"J Pharm Sci"},{"issue":"12","key":"479_CR32","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1007\/s11095-010-0273-9","volume":"27","author":"RS Dhumal","year":"2010","unstructured":"Dhumal RS, Kelly AL, York P, Coates PD, Paradkar A. Cocrystalization and simultaneous agglomeration using hot melt extrusion. Pharm Res. 2010;27(12):2725\u201333. \n                    https:\/\/doi.org\/10.1007\/s11095-010-0273-9\n                    \n                  .","journal-title":"Pharm Res"},{"issue":"1","key":"479_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijpharm.2011.12.033","volume":"426","author":"AL Kelly","year":"2012","unstructured":"Kelly AL, Gough T, Dhumal R, Halsey S, Paradkar A. Monitoring ibuprofen\u2013nicotinamide cocrystal formation during solvent free continuous cocrystallization (SFCC) using near infrared spectroscopy as a PAT tool. Int J Pharm. 2012;426(1):15\u201320. \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2011.12.033\n                    \n                  .","journal-title":"Int J Pharm"},{"issue":"3","key":"479_CR34","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3390\/pharmaceutics3030582","volume":"3","author":"D Daurio","year":"2011","unstructured":"Daurio D, Medina C, Saw R, Nagapudi K, Alvarez-N\u00fa\u00f1ez F. Application of twin screw extrusion in the manufacture of cocrystals, part I: four case studies. Pharmaceutics. 2011;3(3):582\u2013600. \n                    https:\/\/doi.org\/10.3390\/pharmaceutics3030582\n                    \n                  .","journal-title":"Pharmaceutics"},{"issue":"12","key":"479_CR35","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1021\/acs.cgd.5b00806","volume":"15","author":"C Kulkarni","year":"2015","unstructured":"Kulkarni C, Wood C, Kelly AL, Gough T, Blagden N, Paradkar A. Stoichiometric control of co-crystal formation by solvent free continuous co-crystallization (SFCC). Cryst Growth Des. 2015;15(12):5648\u201351. \n                    https:\/\/doi.org\/10.1021\/acs.cgd.5b00806\n                    \n                  .","journal-title":"Cryst Growth Des"},{"issue":"9","key":"479_CR36","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1002\/jps.23983","volume":"103","author":"K Boksa","year":"2014","unstructured":"Boksa K, Otte A, Pinal R. Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion. J Pharm Sci. 2014;103(9):2904\u201310. \n                    https:\/\/doi.org\/10.1002\/jps.23983\n                    \n                  .","journal-title":"J Pharm Sci"},{"key":"479_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1039\/C3FD00153A","volume":"170","author":"D Daurio","year":"2014","unstructured":"Daurio D, Nagapudi K, Li L, Quan P, Nunez F-A. Application of twin screw extrusion to the manufacture of cocrystals: scale-up of AMG 517\u2013sorbic acid cocrystal production. Faraday Discuss. 2014;170:235\u201349. \n                    https:\/\/doi.org\/10.1039\/C3FD00153A\n                    \n                  .","journal-title":"Faraday Discuss"},{"issue":"17","key":"479_CR38","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1039\/C3CE42457J","volume":"16","author":"HG Moradiya","year":"2014","unstructured":"Moradiya HG, Islam MT, Halsey S, Maniruzzaman M, Chowdhry BZ, Snowden MJ, et al. Continuous cocrystallisation of carbamazepine and trans-cinnamic acid via melt extrusion processing. CrystEngComm. 2014;16(17):3573\u201383. \n                    https:\/\/doi.org\/10.1039\/C3CE42457J\n                    \n                  .","journal-title":"CrystEngComm"},{"issue":"3","key":"479_CR39","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s11095-011-0605-4","volume":"29","author":"X Liu","year":"2012","unstructured":"Liu X, Lu M, Guo Z, Huang L, Feng X, Wu C. Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion. Pharm Res. 2012;29(3):806\u201317. \n                    https:\/\/doi.org\/10.1007\/s11095-011-0605-4\n                    \n                  .","journal-title":"Pharm Res"},{"issue":"2","key":"479_CR40","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.drudis.2016.11.007","volume":"22","author":"M Maniruzzaman","year":"2017","unstructured":"Maniruzzaman M, Nokhodchi A. Continuous manufacturing via hot-melt extrusion and scale up: regulatory matters. Drug Discov Today. 2017;22(2):340\u201351. \n                    https:\/\/doi.org\/10.1016\/j.drudis.2016.11.007\n                    \n                  .","journal-title":"Drug Discov Today"},{"issue":"1","key":"479_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2116\/analsci.33.41","volume":"33","author":"R Tanaka","year":"2017","unstructured":"Tanaka R, Takahashi N, Nakamura Y, Hattori Y, Ashizawa K, Otsuka M. In-line and real-time monitoring of resonant acoustic mixing by near-infrared spectroscopy combined with chemometric technology for process analytical technology applications in pharmaceutical powder blending systems. Analytical Sci. 2017;33(1):41\u20136. \n                    https:\/\/doi.org\/10.2116\/analsci.33.41\n                    \n                  .","journal-title":"Analytical Sci"},{"issue":"2","key":"479_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1021\/op4003399","volume":"18","author":"DJ Am Ende","year":"2014","unstructured":"Am Ende DJ, Anderson SR, Salan JS. Development and scale-up of cocrystals using resonant acoustic mixing. Org Process Res Dev. 2014;18(2):331\u201341. \n                    https:\/\/doi.org\/10.1021\/op4003399\n                    \n                  .","journal-title":"Org Process Res Dev"},{"issue":"1","key":"479_CR43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ijpharm.2017.02.027","volume":"521","author":"K Nagapudi","year":"2017","unstructured":"Nagapudi K, Umanzor EY, Masui C. High-throughput screening and scale-up of cocrystals using resonant acoustic mixing. Int J Pharm. 2017;521(1):337\u201345. \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2017.02.027\n                    \n                  .","journal-title":"Int J Pharm"},{"issue":"5","key":"479_CR44","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/prep.201400092","volume":"39","author":"SR Anderson","year":"2014","unstructured":"Anderson SR, Am Ende DJ, Salan JS, Samuels P. Preparation of an energetic-energetic cocrystal using resonant acoustic mixing. Propellants Explos Pyrotech. 2014;39(5):637\u201340. \n                    https:\/\/doi.org\/10.1002\/prep.201400092\n                    \n                  .","journal-title":"Propellants Explos Pyrotech"},{"issue":"30","key":"479_CR45","doi-asserted-by":"publisher","first-page":"8409","DOI":"10.1021\/acs.iecr.6b01938","volume":"55","author":"S Patil","year":"2016","unstructured":"Patil S, Kulkarni J, Mahadik K. Exploring the potential of electrospray technology in cocrystal synthesis. Ind Eng Chem Res. 2016;55(30):8409\u201314. \n                    https:\/\/doi.org\/10.1021\/acs.iecr.6b01938\n                    \n                  .","journal-title":"Ind Eng Chem Res"},{"issue":"7","key":"479_CR46","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1021\/cg300285w","volume":"12","author":"N Radacsi","year":"2012","unstructured":"Radacsi N, Ambrus R, Szunyogh T, Szab\u00f3-R\u00e9v\u00e9sz P, Stankiewicz A, Van Der Heijden A, et al. Electrospray crystallization for nanosized pharmaceuticals with improved properties. Cryst Growth Des. 2012;12(7):3514\u201320. \n                    https:\/\/doi.org\/10.1021\/cg300285w\n                    \n                  .","journal-title":"Cryst Growth Des"},{"issue":"3","key":"479_CR47","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/jps.23024","volume":"101","author":"M Wang","year":"2012","unstructured":"Wang M, Rutledge GC, Myerson AS, Trout BL. Production and characterization of carbamazepine nanocrystals by electrospraying for continuous pharmaceutical manufacturing. J Pharm Sci. 2012;101(3):1178\u201388. \n                    https:\/\/doi.org\/10.1002\/jps.23024\n                    \n                  .","journal-title":"J Pharm Sci"},{"key":"479_CR48","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jddst.2017.04.001","volume":"39","author":"S Patil","year":"2017","unstructured":"Patil S, Ujalambkar V, Mahadik A. Electrospray technology as a probe for cocrystal synthesis: influence of solvent and coformer structure. J Drug Deliv Sci Technol. 2017;39:217\u201322. \n                    https:\/\/doi.org\/10.1016\/j.jddst.2017.04.001\n                    \n                  .","journal-title":"J Drug Deliv Sci Technol"},{"key":"479_CR49","doi-asserted-by":"publisher","unstructured":"Patil S, Chaudhari K, Kamble R. Electrospray technique for cocrystallization of phytomolecules. J King Saud Univ Sci. 2018;30(1):138-41. \n                    https:\/\/doi.org\/10.1016\/j.jksus.2017.04.001","DOI":"10.1016\/j.jksus.2017.04.001"},{"issue":"3","key":"479_CR50","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.addr.2007.08.030","volume":"60","author":"I Pasquali","year":"2008","unstructured":"Pasquali I, Bettini R, Giordano F. Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals. Adv Drug Deliv Rev. 2008;60(3):399\u2013410. \n                    https:\/\/doi.org\/10.1016\/j.addr.2007.08.030\n                    \n                  .","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"479_CR51","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s11095-014-1498-9","volume":"32","author":"KC M\u00fcllers","year":"2015","unstructured":"M\u00fcllers KC, Paisana M, Wahl MA. Simultaneous formation and micronization of pharmaceutical cocrystals by rapid expansion of supercritical solutions (RESS). Pharm Res. 2015;32(2):702\u201313. \n                    https:\/\/doi.org\/10.1007\/s11095-014-1498-9\n                    \n                  .","journal-title":"Pharm Res"},{"key":"479_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jcou.2015.11.006","volume":"13","author":"IA Cuadra","year":"2016","unstructured":"Cuadra IA, Caba\u00f1as A, Cheda JA, Mart\u00ednez-Casado FJ, Pando C. Pharmaceutical co-crystals of the anti-inflammatory drug diflunisal and nicotinamide obtained using supercritical CO 2 as an antisolvent. J CO2 Util. 2016;13:29\u201337.","journal-title":"J CO2 Util"},{"issue":"1","key":"479_CR53","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.supflu.2010.01.010","volume":"53","author":"L Padrela","year":"2010","unstructured":"Padrela L, Rodrigues MA, Velaga SP, Fernandes AC, Matos HA, de Azevedo EG. Screening for pharmaceutical cocrystals using the supercritical fluid enhanced atomization process. J Supercrit Fluids. 2010;53(1):156\u201364. \n                    https:\/\/doi.org\/10.1016\/j.supflu.2010.01.010\n                    \n                  .","journal-title":"J Supercrit Fluids"},{"key":"479_CR54","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.cej.2016.05.129","volume":"303","author":"C Neurohr","year":"2016","unstructured":"Neurohr C, Erriguible A, Laugier S, Subra-Paternault P. Challenge of the supercritical antisolvent technique SAS to prepare cocrystal-pure powders of naproxen-nicotinamide. Chem Eng J. 2016;303:238\u201351. \n                    https:\/\/doi.org\/10.1016\/j.cej.2016.05.129\n                    \n                  .","journal-title":"Chem Eng J"},{"key":"479_CR55","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jcou.2016.12.007","volume":"17","author":"G Kotbantao","year":"2017","unstructured":"Kotbantao G, Charoenchaitrakool M. Processing of ketoconazole\u20134-aminobenzoic acid cocrystals using dense CO 2 as an antisolvent. J CO2 Util. 2017;17:213\u20139. \n                    https:\/\/doi.org\/10.1016\/j.jcou.2016.12.007\n                    \n                  .","journal-title":"J CO2 Util"},{"key":"479_CR56","first-page":"89","volume":"8","author":"S Hiendrawan","year":"2016","unstructured":"Hiendrawan S, Veriansyah B, Widjojokusumo E, Soewandhi S, Wikarsa S, Tjandrawinata RR. Simultaneous cocrystallization and micronization of paracetamol-dipicolinic acid cocrystal by supercritical antisolvent (SAS). Int J Pharm Pharm Sci. 2016;8:89\u201398.","journal-title":"Int J Pharm Pharm Sci"},{"key":"479_CR57","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.supflu.2013.12.011","volume":"86","author":"L Padrela","year":"2014","unstructured":"Padrela L, Rodrigues MA, Tiago J, Velaga SP, Matos HA, de Azevedo EG. Tuning physicochemical properties of theophylline by cocrystallization using the supercritical fluid enhanced atomization technique. J Supercrit Fluids. 2014;86:129\u201336. \n                    https:\/\/doi.org\/10.1016\/j.supflu.2013.12.011\n                    \n                  .","journal-title":"J Supercrit Fluids"},{"issue":"8","key":"479_CR58","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S1369-7021(05)71036-1","volume":"8","author":"PJ Ginty","year":"2005","unstructured":"Ginty PJ, Whitaker MJ, Shakesheff KM, Howdle SM. Drug delivery goes supercritical. Mater Today. 2005;8(8):42\u20138. \n                    https:\/\/doi.org\/10.1016\/S1369-7021(05)71036-1\n                    \n                  .","journal-title":"Mater Today"},{"issue":"1","key":"479_CR59","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1021\/op060170h","volume":"11","author":"DJ Constable","year":"2007","unstructured":"Constable DJ, Jimenez-Gonzalez C, Henderson RK. Perspective on solvent use in the pharmaceutical industry. Org Process Res Dev. 2007;11(1):133\u20137. \n                    https:\/\/doi.org\/10.1021\/op060170h\n                    \n                  .","journal-title":"Org Process Res Dev"},{"issue":"4","key":"479_CR60","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ejps.2005.11.007","volume":"27","author":"I Pasquali","year":"2006","unstructured":"Pasquali I, Bettini R, Giordano F. Solid-state chemistry and particle engineering with supercritical fluids in pharmaceutics. Eur J Pharm Sci. 2006;27(4):299\u2013310. \n                    https:\/\/doi.org\/10.1016\/j.ejps.2005.11.007\n                    \n                  .","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"479_CR61","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ijpharm.2008.05.014","volume":"364","author":"I Pasquali","year":"2008","unstructured":"Pasquali I, Bettini R. Are pharmaceutics really going supercritical? Int J Pharm. 2008;364(2):176\u201387. \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2008.05.014\n                    \n                  .","journal-title":"Int J Pharm"},{"issue":"5","key":"479_CR62","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s40265-014-0204-x","volume":"74","author":"RM Poole","year":"2014","unstructured":"Poole RM, Dungo RT. Ipragliflozin: first global approval. Drugs. 2014;74(5):611\u20137. \n                    https:\/\/doi.org\/10.1007\/s40265-014-0204-x\n                    \n                  .","journal-title":"Drugs"},{"issue":"1","key":"479_CR63","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1021\/op400289z","volume":"18","author":"D Bernhardson","year":"2014","unstructured":"Bernhardson D, Brandt TA, Hulford CA, Lehner RS, Preston BR, Price K, et al. Development of an early-phase bulk enabling route to sodium-dependent glucose cotransporter 2 inhibitor ertugliflozin. Org Process Res Dev. 2014;18(1):57\u201365. \n                    https:\/\/doi.org\/10.1021\/op400289z\n                    \n                  .","journal-title":"Org Process Res Dev"},{"issue":"4","key":"479_CR64","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1021\/acs.cgd.6b01848","volume":"17","author":"C Almansa","year":"2017","unstructured":"Almansa C, Merc\u00e8 R, Tesson N, Farran J, Tom\u00e0s J, Plata-Salam\u00e1n CR. Co-crystal of tramadol hydrochloride\u2013celecoxib (ctc): a novel API\u2013API co-crystal for the treatment of pain. Cryst Growth Des. 2017;17(4):1884\u201392. \n                    https:\/\/doi.org\/10.1021\/acs.cgd.6b01848\n                    \n                  .","journal-title":"Cryst Growth Des"},{"issue":"2","key":"479_CR65","first-page":"o129","volume":"63","author":"WT Harrison","year":"2007","unstructured":"Harrison WT, Yathirajan H, Bindya S, Anilkumar H. Escitalopram oxalate: co-existence of oxalate dianions and oxalic acid molecules in the same crystal. Acta Crystallogr C: crystal structure. Communications. 2007;63(2):o129\u2013o31.","journal-title":"Communications"},{"key":"479_CR66","unstructured":"US FDA Draft Guidance. PAT\u2014a framework for innovative pharmaceutical manufacturing and Quality Assurance. August; 2003."},{"issue":"1","key":"479_CR67","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ijpharm.2014.06.003","volume":"471","author":"MC Sarragu\u00e7a","year":"2014","unstructured":"Sarragu\u00e7a MC, Ribeiro PR, Santos AO, Silva MC, Lopes JAAPAT. Approach for the on-line monitoring of pharmaceutical co-crystals formation with near infrared spectroscopy. Int J Pharm. 2014;471(1):478\u201384. \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2014.06.003\n                    \n                  .","journal-title":"Int J Pharm"},{"issue":"6","key":"479_CR68","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1021\/cg5001864","volume":"14","author":"K-S Lee","year":"2014","unstructured":"Lee K-S, Kim K-J, Ulrich J. In situ monitoring of cocrystallization of salicylic acid\u20134, 4\u2032-dipyridyl in solution using Raman spectroscopy. Cryst Growth Des. 2014;14(6):2893\u20139. \n                    https:\/\/doi.org\/10.1021\/cg5001864\n                    \n                  .","journal-title":"Cryst Growth Des"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-018-0479-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-018-0479-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-018-0479-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T02:06:43Z","timestamp":1569463603000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-018-0479-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,19]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1007\/s13346-018-0479-7","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,19]]},"assertion":[{"value":"19 January 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}